100 related articles for article (PubMed ID: 8725487)
21. Solubilization and purification of bone morphogenetic protein (BMP) from Dunn osteosarcoma.
Hanamura H; Higuchi Y; Nakagawa M; Iwata H; Urist MR
Clin Orthop Relat Res; 1980; (153):232-40. PubMed ID: 6934861
[TBL] [Abstract][Full Text] [Related]
22. Purification of rabbit bone morphogenetic protein derived from bone, dentin, and wound tissue after tooth extraction.
Bessho K; Tagawa T; Murata M
J Oral Maxillofac Surg; 1990 Feb; 48(2):162-9. PubMed ID: 2299457
[TBL] [Abstract][Full Text] [Related]
23. Partial purification and osteoinductive activity of swine bone morphogenetic protein.
Jin DD; Ou BP
Chin Med J (Engl); 1991 Oct; 104(10):863-7. PubMed ID: 1752146
[TBL] [Abstract][Full Text] [Related]
24. Urine release of systemically administered bone morphogenetic protein hybrid molecule.
Grgurevic L; Macek B; Erjavec I; Mann M; Vukicevic S
J Nephrol; 2007; 20(3):311-9. PubMed ID: 17557264
[TBL] [Abstract][Full Text] [Related]
25. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
[TBL] [Abstract][Full Text] [Related]
26. High yield of osteoinductivity can be derived from demineralized bone matrix using collagenase digestion.
Jortikka L; Marttinen A; Lindholm TS
Ann Chir Gynaecol Suppl; 1993; 207():31-5. PubMed ID: 8154834
[TBL] [Abstract][Full Text] [Related]
27. Purification of bone morphogenetic protein derived from bovine bone matrix.
Bessho K; Tagawa T; Murata M
Biochem Biophys Res Commun; 1989 Dec; 165(2):595-601. PubMed ID: 2597148
[TBL] [Abstract][Full Text] [Related]
28. Intact growth factors are conserved in the extracellular matrix of ancient human bone and teeth: a storehouse for the study of human evolution in health and disease.
Schmidt-Schultz TH; Schultz M
Biol Chem; 2005 Aug; 386(8):767-76. PubMed ID: 16201872
[TBL] [Abstract][Full Text] [Related]
29. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix.
Pietrzak WS; Woodell-May J; McDonald N
J Craniofac Surg; 2006 Jan; 17(1):84-90. PubMed ID: 16432413
[TBL] [Abstract][Full Text] [Related]
30. Dentin resorption and cementum-like tissue formation by bone morphogenetic protein application.
Miyaji H; Sugaya T; Kato K; Kawamura N; Tsuji H; Kawanami M
J Periodontal Res; 2006 Aug; 41(4):311-5. PubMed ID: 16827725
[TBL] [Abstract][Full Text] [Related]
31. Purification of monocomponent bovine bone morphogenetic protein in a water-soluble form.
Jortikka L; Marttinen A; Lindholm TS
Ann Chir Gynaecol Suppl; 1993; 207():25-30. PubMed ID: 8154831
[TBL] [Abstract][Full Text] [Related]
32. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products.
Bae HW; Zhao L; Kanim LE; Wong P; Delamarter RB; Dawson EG
Spine (Phila Pa 1976); 2006 May; 31(12):1299-306; discussion 1307-8. PubMed ID: 16721289
[TBL] [Abstract][Full Text] [Related]
33. Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model.
Honsawek S; Powers RM; Wolfinbarger L
Cell Tissue Bank; 2005; 6(1):13-23. PubMed ID: 15735897
[TBL] [Abstract][Full Text] [Related]
34. Activity and solubility of bone morphogenetic protein derived from porcine bone matrix.
Bessho K; Iizuka T
Br J Oral Maxillofac Surg; 1994 Apr; 32(2):86-90. PubMed ID: 8199154
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type).
Takaoka K; Yoshikawa H; Hashimoto J; Miyamoto S; Masuhara K; Nakahara H; Matsui M; Ono K
Clin Orthop Relat Res; 1993 Jul; (292):329-36. PubMed ID: 8519128
[TBL] [Abstract][Full Text] [Related]
36. Demineralized bone-matrix-induced osteogenesis.
Harakas NK
Clin Orthop Relat Res; 1984 Sep; (188):239-51. PubMed ID: 6380863
[TBL] [Abstract][Full Text] [Related]
37. Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue.
Shintani N; Hunziker EB
Arthritis Rheum; 2007 Jun; 56(6):1869-79. PubMed ID: 17530715
[TBL] [Abstract][Full Text] [Related]
38. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
[TBL] [Abstract][Full Text] [Related]
40. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.
Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J
Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
